Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

John Giacona, PhD, PA-C, discusses building a comprehensive multidisciplinary care team for interstitial lung disease and how APPs should engage with clinical evidence.

Multidisciplinary Care, Evidence-Based Practice in ILD: John Giacona, PhD

John Giacona, PhD, PA-C, discusses the cardiology perspective on screening for and managing pulmonary hypertension in interstitial lung disease.

Cardiology's Role in Identifying Pulmonary Hypertension in ILD

Bryan Wells, MD, breaks down new data from 3 universities that have produced a relatively consistent peak systolic velocity, indicating the potential for broad treatment guidelines.

FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines

Mohammed Chowdhury, MD, a Temple University cardiologist, says the field is 2 to 5 years from routine clinical integration — but validation and insurance coverage remain the critical hurdles.


AI-Powered ECG and Echo Could Shrink 2.5-Year Diagnostic Delay in PH

The Voluntary Sodium Reduction Goals, issued in October 2021, resulted in no significant reduction in sodium content among packaged foods.

FDA-Issued Sodium Targets Ineffective in Reducing Dietary Salt Intake

Abbas Zaidi, MD, discusses his recent study providing 5 pain points and 5 suggested improvements for the pediatric hypertension treatment flow.

Q&A: How to Optimize Pediatric Hypertension Diagnosis and Treatment

Beyond hemodynamics and treatment targets, McDevitt says the most important conversations APPs have with patients are often the ones that don't appear in guidelines.


Caring for the Whole Person With Pulmonary Hypertension, With Susanne McDevitt, DNP

From tighter hemodynamic definitions to a first-in-class activin signaling inhibitor, a nearly 30-year PH veteran says the field has never had more to offer patients — or more complexity to manage.

Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP

Rishi Wadhera, MD, MPP, MPhil, addresses performance metrics, cross-specialty prescribing, and the policy forces reshaping the cardiometabolic care cascade.

Q&A: CKM Care, IRA Policy, and Specialty Silos, With Rishi Wadhera, MD, MPP, MPhil

Panelists reached broad consensus that upfront dual oral combination therapy with an ERA and PDE5 inhibitor remains the foundational standard.

PAH Expert Forum: The Limits of Upfront Therapy

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.